These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19598290)

  • 1. Synthesis and characterization of new liver targeting 5-fluorouracil-cholic acid conjugates.
    Qian S; Wu JB; Wu XC; Li J; Wu Y
    Arch Pharm (Weinheim); 2009 Sep; 342(9):513-20. PubMed ID: 19598290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
    Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
    Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
    Singh P; Gupta U; Asthana A; Jain NK
    Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
    Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
    Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
    Jin Y; Yang F; Du L
    Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel thermosensitive 5-fluorouracil-cyclotriphosphazene conjugates: synthesis, thermosensitivity, degradability, and in vitro antitumor activity.
    Cho YW; Lee JR; Song SC
    Bioconjug Chem; 2005; 16(6):1529-35. PubMed ID: 16287251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
    Mohammed MO; Hussain KS; Haj NQ
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro drug release investigation of new potential 5-FU prodrugs.
    Daumar P; Decombat C; Chezal JM; Debiton E; Madesclaire M; Coudert P; Galmier MJ
    Eur J Med Chem; 2011 Jul; 46(7):2867-79. PubMed ID: 21530016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of prodrugs of tacrine hydrochloride and evaluation of the stability and biodistribution in mice].
    Jiang Y; Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Dec; 38(12):962-5. PubMed ID: 15040096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization.
    Chen DQ; Wang X; Chen L; He JX; Miao ZH; Shen JK
    Acta Pharmacol Sin; 2011 May; 32(5):664-72. PubMed ID: 21516131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.
    Roberts WJ; Sloan KB
    J Pharm Sci; 2003 May; 92(5):1028-36. PubMed ID: 12712422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pro-drug therapy in the treatment of cancer.
    Ferguson MJ; Ahmed FY; Cassidy J
    Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil.
    Zhang Z; Hatta H; Ito T; Nishimoto S
    Org Biomol Chem; 2005 Feb; 3(4):592-6. PubMed ID: 15703793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in rats].
    Wang GH; Wang J; Qi W; Chen Y; Sun LX
    Yao Xue Xue Bao; 2008 Jan; 43(1):81-5. PubMed ID: 18357738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
    Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
    Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.